Annual Net Income
-$7.68 M
+$272.00 K+3.42%
30 June 2024
Summary:
InMed Pharmaceuticals annual net profit is currently -$7.68 million, with the most recent change of +$272.00 thousand (+3.42%) on 30 June 2024. During the last 3 years, it has risen by +$2.53 million (+24.77%). INM annual net income is now -16335.97% below its all-time high of -$46.70 thousand, reached on 30 June 2013.INM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$1.68 M
+$259.80 K+13.41%
30 September 2024
Summary:
InMed Pharmaceuticals quarterly net profit is currently -$1.68 million, with the most recent change of +$259.80 thousand (+13.41%) on 30 September 2024. Over the past year, it has increased by +$858.90 thousand (+33.86%). INM quarterly net income is now -1904.19% below its all-time high of $93.00 thousand, reached on 30 June 2009.INM Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$6.82 M
+$858.90 K+11.19%
30 September 2024
Summary:
InMed Pharmaceuticals TTM net profit is currently -$6.82 million, with the most recent change of +$858.90 thousand (+11.19%) on 30 September 2024. Over the past year, it has increased by +$157.50 thousand (+2.26%). INM TTM net income is now -19156.21% below its all-time high of -$35.40 thousand, reached on 30 September 2013.INM TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INM Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.4% | +33.9% | +2.3% |
| 3 y3 years | +24.8% | +43.5% | +41.1% |
| 5 y5 years | +24.0% | +40.2% | +36.5% |
INM Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +58.7% | -395.8% | +78.7% | -12.2% | +64.4% |
| 5 y | 5 years | at high | +58.7% | -395.8% | +78.7% | -12.2% | +64.4% |
| alltime | all time | <-9999.0% | +58.7% | -1904.2% | +78.7% | <-9999.0% | +64.4% |
InMed Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.68 M(-13.4%) | -$6.82 M(-11.2%) |
| June 2024 | -$7.68 M(-3.4%) | -$1.94 M(+12.5%) | -$7.68 M(+26.3%) |
| Mar 2024 | - | -$1.72 M(+16.6%) | -$6.08 M(-4.3%) |
| Dec 2023 | - | -$1.48 M(-41.7%) | -$6.35 M(-8.9%) |
| Sept 2023 | - | -$2.54 M(+649.6%) | -$6.97 M(-12.2%) |
| June 2023 | -$7.95 M(-57.3%) | -$338.40 K(-83.1%) | -$7.95 M(-48.7%) |
| Mar 2023 | - | -$2.00 M(-4.9%) | -$15.48 M(-8.7%) |
| Dec 2022 | - | -$2.10 M(-40.1%) | -$16.96 M(-11.4%) |
| Sept 2022 | - | -$3.51 M(-55.4%) | -$19.14 M(+2.9%) |
| June 2022 | -$18.60 M(+82.3%) | -$7.87 M(+126.4%) | -$18.60 M(+33.0%) |
| Mar 2022 | - | -$3.48 M(-18.8%) | -$13.99 M(+2.7%) |
| Dec 2021 | - | -$4.28 M(+44.1%) | -$13.61 M(+17.6%) |
| Sept 2021 | - | -$2.97 M(-8.8%) | -$11.58 M(+13.5%) |
| June 2021 | -$10.20 M(+14.1%) | -$3.26 M(+5.1%) | -$10.20 M(+19.2%) |
| Mar 2021 | - | -$3.10 M(+38.2%) | -$8.56 M(+14.4%) |
| Dec 2020 | - | -$2.24 M(+40.3%) | -$7.48 M(-3.2%) |
| Sept 2020 | - | -$1.60 M(-1.1%) | -$7.73 M(-13.5%) |
| June 2020 | -$8.94 M(-11.5%) | -$1.62 M(-20.1%) | -$8.94 M(-16.4%) |
| Mar 2020 | - | -$2.02 M(-18.8%) | -$10.69 M(-5.2%) |
| Dec 2019 | - | -$2.49 M(-11.1%) | -$11.28 M(+5.1%) |
| Sept 2019 | - | -$2.81 M(-16.7%) | -$10.73 M(+6.0%) |
| June 2019 | -$10.10 M(+55.8%) | -$3.37 M(+28.8%) | -$10.13 M(+12.7%) |
| Mar 2019 | - | -$2.61 M(+34.2%) | -$8.99 M(+12.0%) |
| Dec 2018 | - | -$1.95 M(-11.4%) | -$8.02 M(+9.9%) |
| Sept 2018 | - | -$2.20 M(-1.2%) | -$7.30 M(+11.1%) |
| June 2018 | -$6.48 M(+88.3%) | -$2.23 M(+35.1%) | -$6.57 M(+12.6%) |
| Mar 2018 | - | -$1.65 M(+34.2%) | -$5.83 M(+14.0%) |
| Dec 2017 | - | -$1.23 M(-16.3%) | -$5.12 M(+11.5%) |
| Sept 2017 | - | -$1.47 M(-1.6%) | -$4.59 M(+33.4%) |
| June 2017 | -$3.44 M(+87.2%) | -$1.49 M(+60.3%) | -$3.44 M(+46.8%) |
| Mar 2017 | - | -$930.50 K(+33.2%) | -$2.34 M(+37.3%) |
| Dec 2016 | - | -$698.80 K(+119.8%) | -$1.71 M(+9.0%) |
| Sept 2016 | - | -$317.90 K(-19.5%) | -$1.57 M(-11.3%) |
| June 2016 | -$1.84 M(-46.9%) | -$394.80 K(+34.0%) | -$1.76 M(-31.8%) |
| Mar 2016 | - | -$294.60 K(-47.3%) | -$2.59 M(-27.6%) |
| Dec 2015 | - | -$558.60 K(+8.2%) | -$3.57 M(+2.0%) |
| Sept 2015 | - | -$516.40 K(-57.5%) | -$3.50 M(-1.9%) |
| June 2015 | -$3.46 M(+200.1%) | -$1.22 M(-5.1%) | -$3.57 M(+5.9%) |
| Mar 2015 | - | -$1.28 M(+162.6%) | -$3.37 M(+54.5%) |
| Dec 2014 | - | -$487.80 K(-16.5%) | -$2.18 M(+26.2%) |
| Sept 2014 | - | -$584.40 K(-42.5%) | -$1.73 M(+49.7%) |
| June 2014 | -$1.15 M(+2367.2%) | -$1.02 M(+1000.4%) | -$1.15 M(+615.6%) |
| Mar 2014 | - | -$92.30 K(+162.2%) | -$161.30 K(+110.6%) |
| Dec 2013 | - | -$35.20 K(+220.0%) | -$76.60 K(+116.4%) |
| Sept 2013 | - | -$11.00 K(-51.8%) | -$35.40 K(-25.2%) |
| June 2013 | -$46.70 K | -$22.80 K(+200.0%) | -$47.30 K(-61.5%) |
| Mar 2013 | - | -$7600.00(-226.7%) | -$122.90 K(-10.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | - | $6000.00(-126.2%) | -$138.00 K(-19.0%) |
| Sept 2012 | - | -$22.90 K(-76.7%) | -$170.30 K(-9.3%) |
| June 2012 | -$189.90 K(-41.7%) | -$98.40 K(+333.5%) | -$187.70 K(+89.2%) |
| Mar 2012 | - | -$22.70 K(-13.7%) | -$99.20 K(-66.5%) |
| Dec 2011 | - | -$26.30 K(-34.7%) | -$296.10 K(-4.2%) |
| Sept 2011 | - | -$40.30 K(+307.1%) | -$309.00 K(-3.8%) |
| June 2011 | -$325.50 K(-2.8%) | -$9900.00(-95.5%) | -$321.20 K(-15.6%) |
| Mar 2011 | - | -$219.60 K(+460.2%) | -$380.50 K(+49.9%) |
| Dec 2010 | - | -$39.20 K(-25.3%) | -$253.80 K(-16.0%) |
| Sept 2010 | - | -$52.50 K(-24.1%) | -$302.20 K(-8.0%) |
| June 2010 | -$334.80 K(-68.4%) | -$69.20 K(-25.5%) | -$328.50 K(+97.5%) |
| Mar 2010 | - | -$92.90 K(+6.1%) | -$166.30 K(-0.3%) |
| Dec 2009 | - | -$87.60 K(+11.2%) | -$166.80 K(-50.7%) |
| Sept 2009 | - | -$78.80 K(-184.7%) | -$338.50 K(-72.4%) |
| June 2009 | -$1.06 M(+14.9%) | $93.00 K(-199.6%) | -$1.23 M(-21.3%) |
| Mar 2009 | - | -$93.40 K(-64.0%) | -$1.56 M(-5.7%) |
| Dec 2008 | - | -$259.30 K(-73.1%) | -$1.65 M(-9.1%) |
| Sept 2008 | - | -$965.70 K(+305.6%) | -$1.82 M(+62.2%) |
| June 2008 | -$922.30 K(-50.8%) | -$238.10 K(+26.9%) | -$1.12 M(-35.3%) |
| Mar 2008 | - | -$187.70 K(-55.8%) | -$1.73 M(-2.3%) |
| Dec 2007 | - | -$424.30 K(+57.4%) | -$1.77 M(-8.1%) |
| Sept 2007 | - | -$269.50 K(-68.3%) | -$1.93 M(-2.1%) |
| June 2007 | -$1.87 M(+47.3%) | -$848.90 K(+271.8%) | -$1.97 M(+48.2%) |
| Mar 2007 | - | -$228.30 K(-60.7%) | -$1.33 M(-14.2%) |
| Dec 2006 | - | -$580.90 K(+86.5%) | -$1.55 M(+25.7%) |
| Sept 2006 | - | -$311.40 K(+49.4%) | -$1.23 M(-3.5%) |
| June 2006 | -$1.27 M(-54.2%) | -$208.40 K(-53.4%) | -$1.28 M(-47.3%) |
| Mar 2006 | - | -$447.60 K(+69.4%) | -$2.42 M(+5.5%) |
| Dec 2005 | - | -$264.30 K(-25.7%) | -$2.29 M(-4.7%) |
| Sept 2005 | - | -$355.90 K(-73.7%) | -$2.41 M(-12.5%) |
| June 2005 | -$2.78 M(+82.8%) | -$1.35 M(+319.7%) | -$2.75 M(+31.1%) |
| Mar 2005 | - | -$322.20 K(-14.8%) | -$2.10 M(+3.2%) |
| Dec 2004 | - | -$378.00 K(-45.9%) | -$2.03 M(+3.5%) |
| Sept 2004 | - | -$698.90 K(-0.2%) | -$1.97 M(+27.6%) |
| July 2004 | -$1.52 M(+23.5%) | -$700.20 K(+172.7%) | -$1.54 M(+23.0%) |
| Apr 2004 | - | -$256.80 K(-17.1%) | -$1.25 M(+3.7%) |
| Jan 2004 | - | -$309.70 K(+12.9%) | -$1.21 M(+4.1%) |
| Oct 2003 | - | -$274.20 K(-33.5%) | -$1.16 M(-2.3%) |
| July 2003 | -$1.23 M(-54.6%) | -$412.40 K(+94.7%) | -$1.19 M(-10.4%) |
| Apr 2003 | - | -$211.80 K(-19.1%) | -$1.33 M(-25.7%) |
| Jan 2003 | - | -$261.80 K(-13.3%) | -$1.78 M(-20.8%) |
| Oct 2002 | - | -$301.80 K(-45.1%) | -$2.25 M(-16.4%) |
| July 2002 | -$2.71 M(-36.5%) | -$550.00 K(-17.9%) | -$2.70 M(+25.6%) |
| Apr 2002 | - | -$670.00 K(-8.3%) | -$2.15 M(+45.4%) |
| Jan 2002 | - | -$730.50 K(-1.9%) | -$1.48 M(+98.1%) |
| Oct 2001 | - | -$744.60 K | -$744.60 K |
| July 2001 | -$4.27 M | - | - |
FAQ
- What is InMed Pharmaceuticals annual net profit?
- What is the all time high annual net income for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual net income year-on-year change?
- What is InMed Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals quarterly net income year-on-year change?
- What is InMed Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals TTM net income year-on-year change?
What is InMed Pharmaceuticals annual net profit?
The current annual net income of INM is -$7.68 M
What is the all time high annual net income for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual net profit is -$46.70 K
What is InMed Pharmaceuticals annual net income year-on-year change?
Over the past year, INM annual net profit has changed by +$272.00 K (+3.42%)
What is InMed Pharmaceuticals quarterly net profit?
The current quarterly net income of INM is -$1.68 M
What is the all time high quarterly net income for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly net profit is $93.00 K
What is InMed Pharmaceuticals quarterly net income year-on-year change?
Over the past year, INM quarterly net profit has changed by +$858.90 K (+33.86%)
What is InMed Pharmaceuticals TTM net profit?
The current TTM net income of INM is -$6.82 M
What is the all time high TTM net income for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high TTM net profit is -$35.40 K
What is InMed Pharmaceuticals TTM net income year-on-year change?
Over the past year, INM TTM net profit has changed by +$157.50 K (+2.26%)